Edesa Biotech
EDSA
18 hedge funds and large institutions have $718K invested in Edesa Biotech in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
11% more capital invested
Capital invested by funds: $645K → $718K (+$73.1K)
6% more funds holding
Funds holding: 17 → 18 (+1)
0.28% more ownership
Funds ownership: 4.68% → 4.96% (+0.28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$90.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.8K |
| 3 |
AW
Avion Wealth
The Woodlands,
Texas
|
+$1.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5 |
| 5 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$46K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.5K |
EDSA Hedge Fund Activity: Q3 2024 in Review
18 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2024, worth a combined $718K — up 11% from $645K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was CM Management, adding an estimated $90.9K. The largest seller was CIBC World Market, exiting entirely with an estimated $46K sold.
- 18 institutional investors held Edesa Biotech (EDSA) as of Q3 2024, up from 17 in Q2 2024.
- Funds reported $718K of Edesa Biotech stock for Q3 2024, up 11% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q3 2024 was CM Management, an estimated $90.9K added.
- The largest Edesa Biotech seller in Q3 2024 was CIBC World Market, an estimated $46K sold.
Based on aggregated 13F filings for Q3 2024.